Tonix Pharmaceuticals Announces IND Clearance for Skin Test (TNX-2100) to Measure SARS-CoV-2 Exposure and T Cell ImmunityGlobeNewsWire • 12/14/21
Tonix Pharmaceuticals Announces Research Collaboration with Columbia University to Study Recombinant Trefoil Factor 2 (rTFF2)-Based Therapy (TNX-1700) for Gastric and Colorectal CancersGlobeNewsWire • 12/13/21
Tonix Pharmaceuticals Announces FDA Clearance of the IND for Potentiated Intranasal Oxytocin (TNX-1900) for the Prevention of Migraine Headache in Chronic MigraineursGlobeNewsWire • 11/23/21
Tonix Pharmaceuticals Announces Publication of Paper on Antiviral SARS-CoV-2 Inhibitor, TNX-3500, in JCI InsightGlobeNewsWire • 11/22/21
Tonix Pharmaceuticals Presents Phase 1 Formulation Development Data for TNX-601 CR in a Poster Presentation at CNS Summit 2021GlobeNewsWire • 11/09/21
Tonix Pharmaceuticals Presents Positive Results from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia at the American College of Rheumatology Convergence 2021GlobeNewsWire • 11/08/21
Tonix Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational HighlightsGlobeNewsWire • 11/08/21
Tonix Pharmaceuticals Announces Ribbon-Cutting Ceremony for its Infectious Disease R&D Center in MarylandGlobeNewsWire • 10/15/21
Tonix Pharmaceuticals Announces Completion of Acquisition of Infectious Disease R&D Center in Frederick, MarylandGlobeNewsWire • 10/04/21
Tonix Pharmaceuticals Expands Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and TherapeuticsGlobeNewsWire • 09/23/21
Tonix Pharmaceuticals to Present at the Cantor Virtual Global Healthcare ConferenceGlobeNewsWire • 09/22/21
Why Shares of GameStop, Naked Brand Group, and Tonix Pharmaceuticals Were Soaring TodayThe Motley Fool • 08/24/21